Published in Science Translational Medicine · View the paper (DOI)
Researchers have found that increasing mutant MeCP2 protein levels can improve symptoms in mice and cells from patients with Rett syndrome. The approach, which guides brain cells to skip a specific ingredient, has shown promise in treating the rare neurodevelopmental disorder.
Coverage from 2 institutions